FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

JD & SN Inc., dba Moses Lake Professional Pharmacy Sermorelin/Ghrp-6/Ghrp-2 Recall

SERMORELIN/GHRP-6/GHRP-2, Injectable Solution, 9/5

JD & SN Inc., dba Moses Lake Professional Pharmacy · Moses Lake, WA

Risk level
Class II
Reported by FDA
Nov 4, 2015
Recall ID
D-0121-2016
Check your lot numberHow we source this data

Summary

JD & SN Inc., dba Moses Lake Professional Pharmacy recalled Sermorelin/Ghrp-6/Ghrp-2 starting Jul 24, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0121-2016 on Nov 4, 2015. Reason: Lack of Assurance of Sterility; all sterile human compounded drugs within expiry. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

Product description

SERMORELIN/GHRP-6/GHRP-2, Injectable Solution, 9/5.4/5.4MG/9ML, 9mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314

Lot numbers, UPCs & expiration codes

t10062014@19, t09152014@13, t08262014@1, t08072014@20, t05282015@28, t03062015@14, t02162015@26, 12222014@3, 11262014@6, 11172014@4, 11052014@3, 10272014@7, 10222014@23, 10202014@20, 10152014@5, 10012014@17, 09102014@3, 08182014@9, 07222014@31, 06292015@10, 06232014@3, 06222015@6, 05132015@7, 05062015@7, 05042015@4, 04272015@8, 04222015@6, 03302015@11, 03252015@9, 02202015@24, 01232015@20, 01192015@1, 01052015@8.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0121-2016
Classification
Class II
Status
Terminated
Recall initiated
Jul 24, 2015
FDA report date
Nov 4, 2015
Quantity
165 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
JD & SN Inc., dba Moses Lake Professional Pharmacy

Original FDA data

Every field from FDA enforcement report D-0121-2016, exactly as published.

Show all FDA fields
City
Moses Lake
State
WA
Status
Terminated
Country
United States
Event ID
71806
Address
1555 Pilgrim St
Code information
t10062014@19, t09152014@13, t08262014@1, t08072014@20, t05282015@28, t03062015@14, t02162015@26, 12222014@3, 11262014@6, 11172014@4, 11052014@3, 10272014@7, 10222014@23, 10202014@20, 10152014@5, 10012014@17, 09102014@3, 08182014@9, 07222014@31, 06292015@10, 06232014@3, 06222015@6, 05132015@7, 05062015@7, 05042015@4, 04272015@8, 04222015@6, 03302015@11, 03252015@9, 02202015@24, 01232015@20, 01192015@1, 01052015@8.
Postal code
98837-4623
Report date
Nov 4, 2015
Product type
Drugs
Recall number
D-0121-2016
Classification
Class II
Recalling firm
JD & SN Inc., dba Moses Lake Professional Pharmacy
Product quantity
165 syringes
Termination date
Apr 13, 2016
Reason for recall
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Voluntary / mandated
Voluntary: Firm initiated
Product description
SERMORELIN/GHRP-6/GHRP-2, Injectable Solution, 9/5.4/5.4MG/9ML, 9mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
Distribution pattern
Nationwide
Recall initiation date
Jul 24, 2015
Initial firm notification
Press Release
Center classification date
Oct 27, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0121-2016, published Nov 4, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls